Peer-Reviewed Publication
Clin Infect Dis2026;82(6):934-943.July 8, 2026Journal Article

Using Encounter-Level Data for Risk-Adjustment of Antimicrobial Use Comparisons: Feasibility and Variable Selection.

Rebekah W Moehring1, Michael E Yarrington1, Elizabeth Dodds Ashley1, Rachel M Addison1, Whitney R Buckel2, Sara E Cosgrove3, Danielle Doughman4, Eili Klein5, Carlos A Q Santos6, Emily S Spivak7, William Trick8, Michael J Smith9, David J Weber4, Congwen Zhao10, Deverick J Anderson1, Benjamin A Goldstein10
1Department of Medicine, Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina, USA.
2Department of Pharmacy, Intermountain Health, Salt Lake City, Utah, USA.
3Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
4Department of Medicine, University of North Carolina Hospitals, Chapel Hill, North Carolina, USA.
5Department of Emergency Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
6Department of Internal Medicine, Rush University, Chicago, Illinois, USA.
7Department of Medicine, Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, USA.
8Department of Internal Medicine, Cook County Health, Chicago, Illinois, USA.
9Department of Pediatrics, Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina, USA.
10Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

Abstract

BACKGROUND: External comparisons of hospital antimicrobial use (AU), risk-adjusted using encounter characteristics, may better inform antimicrobial stewardship program strategy. Barriers to encounter-level modeling include feasibility of data collection and defining optimal methods for selecting input variables for risk-adjustment purposes. METHODS: We measured achievements in sharing validated,…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.